Inaugural Multidisciplinary CNS Metastasis Update

October 17, 2020

The goal of this educational activity is to present a multidisciplinary approach to the clinical management of CNS metastasis from various cancers, discuss available innovative clinical trial options and provide the latest updates on current techniques in neurosurgical advancements in this arena. Using a disease-orientated multiple specialty approach along with panel discussions, the activity will provide a comprehensive update for providers from multiple disciplines.

Physicians and other healthcare providers locally, regionally and nationally will learn about novel advances in the treatment and management of brain and spine metastasis from common cancers encountered in daily practice.  Participation is encouraged through question and answer opportunities during the program.

Practice Gaps and Needs

Multidisciplinary CNS metastasis update is the first, one of its kind, premier educational event in the region designed to educate a broader oncology committee involved in caring for cancer patients with brain and spine metastasis. Given the unique circumstances this year due to COVID-19, we will also discuss the effect of COVID-19 on oncological care in our community. This course will provide a comprehensive review and update of medical oncology core competencies as outlined by the Medical Oncology Certification Board, as well as instruction on innovations in technology and medical care focused on improved outcomes for patients.

Elements of Competence

This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties' areas of patient care and procedural skills, medical knowledge, and interpersonal and communication skills.
This activity also focuses on the interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.

Target Audience

This activity is designed to educate community general practitioners, oncologists, radiation oncologists, neurosurgeons, advanced practice nurses, PAs, RNs and other healthcare providers on topics relevant to new advances in the diagnosis and treatment of brain and spine metastasis from cancer.

Highlights include:

  • Updates of minimally invasive neurosurgery
  • Updates of medical/radiation oncology clinical trials
  • COVID-19 effect on oncological care

Learning Objectives

At the conclusion of this CE activity, participants will be able to:

  • Discuss communication and collaboration with partners in care of patients.
  • Review best current multi-disciplinary treatment strategy for cancer patients with brain and spine metastasis.
  • Discuss effective patient centric practice management techniques.

Provided by

University of Wisconsin School of Medicine and Public Health
   Department of Neurological Surgery

In Cooperation With

 

Course summary
Available credit: 
  • 7.00 AMA PRA Category 1 Credit
  • 7.00 ANCC Contact Hours
  • 7.00 University of Wisconsin–Madison Continuing Education Hours
Registration opens: 
08/03/2020
Course expires: 
12/31/2021
Event starts: 
10/17/2020 - 7:45am
Event ends: 
10/17/2020 - 4:30pm
Cost:
$50.00
Rating: 
0

Saturday, October 17, 2020

 

7:45 AM

Welcome

Neurological Update
Moderator:  Demi Dawkins, MD

8:00 AM

Stereotactic Radiosurgery for Brain Metastasis
Michael McDermott, MD

8:45 AM

Minimally Invasive Surgical Advances in Brain Surgery
Mahua Dey, MD

9:00 AM

Open Surgery for Brain Metastasis
Mustafa Baskaya, MD

9:15 AM

Surgical Advances in Spine Surgery
Nathaniel Brooks, MD

9:30 AM

Panel Discussion

9:45 AM

BREAK

Oncological Update
Moderator:  Angela Richardson, MD, PhD

10:00 AM

Updates on Breast Cancer Brain Metastases
Carey Anders, MD

10:45 AM

Advances in the Management of CNS Metastasis from Lung Cancer
Ticiana Leal, MD

11:00 AM

Radiation for Breast and Lung Cancer
Michael Bassetti, MD, PhD

11:15 AM

Lung Cancer Study
Narjust Duma, MD

11:30 AM

Panel Discussion

12:00 PM

BREAK

Radiology Oncology Update
Moderator: Dustin Jacqmin, PhD

1:00 PM

Radiation Oncology
Joseph Bovi, MD

1:45 PM

Rad Onc
Andrew Baschnagel, MD

2:00 PM

Rad Onc
Steven Howard, MD, PhD

2:15 PM

Radiosurgery Physics and Technology
Zac Labby, PhD

2:30 PM

Panel Discussion

2:45 PM

BREAK

Patient Care Center
Moderator: Mahua Dey, MD

3:00 PM

COVID-19 and Cancer Care at UWCCC
Ruth O'Regan, MD

3:15 PM

Palliative Care
TBD

3:45 PM

UW CNS Metastasis Multi-D Clinic
Jessica Leiberg, NP

4:00 PM

Panel Discussion

4:30 PM

ADJOURN

THIS IS A VIRTUAL CONFERENCE (CENTRAL DAYLIGHT TIME). PLEASE SEE THE PROGRAM FOR FURTHER INFORMATION.

A LINK TO THE WEBINAR WILL BE SENT TO PARTICIPANTS PRIOR TO THE ACTIVITY START DATE.

Course Director

Mahua Dey, MD; Assistant Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Visiting Faculty

Carey Anders, MD; Medical Director of the Brain and Spine Metastases Program, Professor of Medicine, Duke University School of Medicine, Durham, NC

Joseph Bovi, MD; MCW, Professor of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI

Michael McDermott, MD; Chief Medical Executive of Miami Neuroscience Institute, Professor of Neurosurgery, Baptist Health South Florida, Miami, FL

University of Wisconsin Faculty

Andrew Baschnagel, MD; Human Oncology Director of Clinical Trials, Associate Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health 

Mustafa Baskaya, MD; Director of Skull Base Surgery, Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Michael Bassetti, MD, PhD; Assistant Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health

Nathaniel Brooks, MD; Associate Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Demi Dawkins, MD; Honorary Associate/Fellow of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Mahua Dey, MD; Director of Surgical Neuro-oncology, Assistant Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Narjust Duma, MD; Assistant Professor of Medicine, University of Wisconsin School of Medicine and Public Health

Steven Howard, MD, PhD; Associate Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health

Dustin Jacqmin, PhD; Assistant Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health

Zacariah (Zac) Labby, PhD; Assistant Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health

Ticiana A. Leal, MD; Director of Thoracic Medical Oncology, Assistant Professor of Medicine, University of Wisconsin School of Medicine and Public Health

Jessica Leiberg, NP; Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Ruth O'Regan, MD; Deputy Director of UWCCC and Division Head of Hematology and Oncology, Professor of Medicine, University of Wisconsin School of Medicine and Public Health

Angela Richardson, MD, PhD; Clinical Instructor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Planning Committee

Mahua Dey, MD; Assistant Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Jessica Leiberg, NP; Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health

Ruth O'Regan, MD; Professor of Medicine, University of Wisconsin School of Medicine and Public Health

Terese Bailey, BS; Senior Outreach Specialist, Office of Continuing Development, University of Wisconsin–Madison ICEP

 

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest.  Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).

Name of Individual

Individual’s Role in Activity

Name of Commercial Interest & Nature of Relationship

Discussion of
Unlabeled/
Unapproved
Uses of Drugs/Devices
in Presentation?

Carey Anders, MDSpeakerEisai (Contractor), Eli Lilly and Company (Grant),
Genentech (Contractor), TESARO, Inc. (Grant),
Puma (Grant), Jones and Bartlett Publishing (Otherip),
Merck (Grant), Novartis (Grant), Pfizer (Grant),
Novartis (Contractor), Up to date (Other IP),
AstraZeneca (Contractor), G1-therapeutics (Grant),
Ipsen Biopharmaceuticals, Inc (Contractor),
Seattle Genetics (Contractor), Zion Pharma (Grant),
Seattle Genetics (Grant), Nektar (Grant),
Genentech (Contractor)
Yes
Terese Bailey, BSPlannerNo relevant financial relationships to discloseNo
Andrew Baschnagel, MDSpeakerNo relevant financial relationships to discloseNo
Mustafa Baskaya, MDSpeakerNo relevant financial relationships to discloseNo
Michael Bassetti, MD, PhDSpeakerEMD Serono, Merck, AstraZeneca (Grant)No
Joseph Bovi, MDSpeakerNo relevant financial relationships to discloseNo
Nathaniel Brooks, MDSpeakerNo relevant financial relationships to discloseNo
Demi Dawkins, MDModerator  
Mahua Dey, MDCourse Director, Speaker, ModeratorNo relevant financial relationships to discloseNo
Narjust Duma, MDSpeakerInivata, Inc. AstraZeneca (Contractor)No
Steven Howard, MD, PhDSpeaker  
Dustin Jacqmin, PhDModerator  
Zacariah (Zac) Labby, PhDSpeakerNo relevant financial relationships to discloseNo
Ticiana A. Leal, MDSpeakerGenentech USA, Inc. Merck, EMD Serono, Inc.,
Jazz Pharmaceuticals Inc., Takeda Oncology, AstraZeneca,
Merck, Inivata, Novocure Israel Ltd (Contractor)
No
Jessica Leiberg, NPPlanner & SpeakerNo relevant financial relationships to discloseNo
Ruth O'Regan, MDPlannerMacrogenics, Eli Lilly and Company, Genomic Health,
Biotheranostics, Genentech, PUMA (Contractor);
Genomic Health, Eli Lilly and Company (Travel)
 
Angela Richardson, MD, PhDModerator  

 

 

Discloser List CME Internal Report

Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

CREDIT DESIGNATION STATEMENTS

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.0 ANCC contact hours.

The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. Iowa Board of Nursing accepts ANCC contact hours for nursing continuing education requirements.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison, as a member of the University Professional Continuing Education Association (UPCEA), authorizes this program for 0.7 continuing education units (CEUs) or 7.0 hours.

Available Credit

  • 7.00 AMA PRA Category 1 Credit
  • 7.00 ANCC Contact Hours
  • 7.00 University of Wisconsin–Madison Continuing Education Hours

Price

Cost:
$50.00
Please login or register to take this course.

Registration Fees

$50.00 MD/DO
$25.00 Other healthcare providers
$0.00   Trainees, including fellows, residents and students

Syllabus Materials

Syllabus materials will be posted on this site.  Materials will be available to registered participants 48 hours (October 22) prior to the event. If you want to view the presentations while at the conference, please bring your laptop.

CANCELLATION AND REFUND POLICY

Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the $10 nonrefundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.

PROGRAM CHANGES

Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.

For Further Information

For conference information or details, please contact Mahua Dey, MD by emailing whiting@neurosurgery.wisc.edu.